Recombinant Human KRT17 cell lysate
Cat.No. : | KRT17-953HCL |
- Specification
- Gene Information
- Related Products
Description : | This gene encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex. |
Species : | Human |
Size : | 100 ul |
Storage Buffer : | 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue) |
Applications : | Western Blot; |
Gene Name : | KRT17 keratin 17 [ Homo sapiens ] |
Official Symbol : | KRT17 |
Synonyms : | KRT17; keratin 17; PCHC1; keratin, type I cytoskeletal 17; 39.1; CK-17; keratin-17; cytokeratin-17; keratin 17 epitope S1; keratin 17 epitope S2; keratin 17 epitope S4; PC; K17; PC2; |
Gene ID : | 3872 |
mRNA Refseq : | NM_000422 |
Protein Refseq : | NP_000413 |
MIM : | 148069 |
UniProt ID : | Q04695 |
Chromosome Location : | 17q21.2 |
Pathway : | EGFR1 Signaling Pathway, organism-specific biosystem; Glucocorticoid receptor regulatory network, organism-specific biosystem; |
Function : | protein binding; structural constituent of cytoskeleton; |
Products Types
◆ Recombinant Protein | ||
KRT17-4913M | Recombinant Mouse KRT17 Protein, His (Fc)-Avi-tagged | +Inquiry |
KRT17-611B | Recombinant Bovine KRT17 Protein (1-441 aa), His-SUMO-tagged | +Inquiry |
KRT17-2826H | Recombinant Human KRT17 protein(71-400 aa), C-His-tagged | +Inquiry |
KRT17-2970R | Recombinant Rat KRT17 Protein, His (Fc)-Avi-tagged | +Inquiry |
KRT17-8820M | Recombinant Mouse KRT17 Protein | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionYes, elevated levels of KRT17 protein have been associated with poorer prognosis and higher risk of disease recurrence in cancer patients.
Yes, changes in KRT17 protein levels during treatment can serve as a potential biomarker for assessing treatment response and guiding personalized cancer therapy.
Studies have suggested that higher KRT17 protein levels may be associated with increased metastatic potential in certain types of cancer.
KRT17 protein is typically expressed at low levels in normal tissue, but its expression is significantly upregulated in cancerous tissue.
Yes, immunohistochemistry and immunofluorescence assays are commonly used to measure KRT17 protein expression in cancer tissue samples.
Customer Reviews (3)
Write a reviewWith its purity and reliability, this protein is poised to contribute significantly to the success of my research objectives by providing accurate and reproducible results.
The KRT17 Protein demonstrates remarkable stability and functional efficiency, making it an indispensable tool for diverse scientific applications.
Its versatility allows for exploration of its extensive involvement in various biochemical and biological processes, providing valuable insights into its role and implications.
Ask a Question for All KRT17 Products
Required fields are marked with *
My Review for All KRT17 Products
Required fields are marked with *
Inquiry Basket